Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Improving Clinical Diagnosis Classification and Prognosis Evaluation Criteria and Precise Early Intervention Treatment of High-risk MDS Patients Based on RNA-seq Technology

NCT03903055 is registered in ClinicalTrials.gov with Zhejiang Provincial Hospital of TCM as lead sponsor.

NCT NCT03903055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03903055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Improving Clinical Diagnosis Classification and Prognosis Evaluation Criteria and Precise Early Intervention Treatment of High-risk MDS Patients Based on RNA-seq Technology
Lead sponsor
Zhejiang Provincial Hospital of TCM
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2019
Completion date
December 31, 2022
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mds